METTL3 and kidney cancer: Although, Li et al. (2017) has reported that low expression of METTL3 was related to activations of adipogenesis and mTOR pathways in ccRCCs, the molecular mechanism of METTL3 in regulating of kidney cancer progression via an m6A methyltransferase dependent manner remains largely unclear.